CETERIX ORTHOPAEDICS, INC.
MEMPHIS, TN

Michael has over 15 years of engineering and product development experience. Prior to joining Ceterix, Michael was Vice President of R&D at The Foundry, NewCo XI. He was Director of R&D at Emphasys Medical, R&D Manager at Cardica, Inc., and Mechanical Design Engineer at IDEO. Michael is a co-inventor on over 50 issued and pending U.S. patents. He received an MS in Mechanical Engineering from Stanford University and a BS in Mechanical Engineering from Northwestern University. Mark Saxton brings over 20 years of sales and marketing experience to Ceterix. Prior to joining the company, Mark served as Vice President of Product Solutions for Integer, a global healthcare products leader dedicated to creating innovative medical solutions. His experience at Integer followed a lengthy career with VNUS Medical, which pioneered the market for the minimally invasive treatment of venous reflux disease. As Vice President of Sales, Mark led VNUS to substantial sales growth, resulting in their acquisition by Covidien. Prior to his 10 years with VNUS and Covidien, Mark led efforts to expand the base of business and grow sales at InnerDyne Medical, Inc., a medical device startup, acquired by Covidien (then Tyco), that specialized in novel laparoscopic instruments. In addition, Mark spent six years with PMT Corporation, a leading manufacturer of products for Neurosurgery, Orthopaedics and Plastic and Reconstructive Surgery in various roles of increasing responsibility. Mark holds a BBA in Marketing and Business administration from Western Michigan University. Dr. Justin Saliman practices orthopaedic surgery with a sports focus at Cedars-Sinai Hospital in Los Angeles. He founded and ran the incubator Revolutionary Surgical Device, LLC in late 2007 which went on to create SuturePro Technologies, LLC and Advanced Meniscus Technologies, LLC in 2009. These companies were merged in 2010 to form Ceterix Orthopaedics. Justin completed medical school at the University of Colorado School of Medicine in his hometown of Denver. He completed his residency in orthopaedic surgery at St. Lukes – Roosevelt Hospital center of Columbia University in New York City and a sports fellowship at Stanford University in Palo Alto. Michael has over 15 years of engineering and product development experience. Prior to joining Ceterix, Michael was Vice President of R&D at The Foundry, NewCo XI. He was Director of R&D at Emphasys Medical, R&D Manager at Cardica, Inc., and Mechanical Design Engineer at IDEO. Michael is a co-inventor on over 50 issued and pending U.S. patents. He received an MS in Mechanical Engineering from Stanford University and a BS in Mechanical Engineering from Northwestern University. Mark Saxton brings over 20 years of sales and marketing experience to Ceterix. Prior to joining the company, Mark served as Vice President of Product Solutions for Integer, a global healthcare products leader dedicated to creating innovative medical solutions. His experience at Integer followed a lengthy career with VNUS Medical, which pioneered the market for the minimally invasive treatment of venous reflux disease. As Vice President of Sales, Mark led VNUS to substantial sales growth, resulting in their acquisition by Covidien. Prior to his 10 years with VNUS and Covidien, Mark led efforts to expand the base of business and grow sales at InnerDyne Medical, Inc., a medical device startup, acquired by Covidien (then Tyco), that specialized in novel laparoscopic instruments. In addition, Mark spent six years with PMT Corporation, a leading manufacturer of products for Neurosurgery, Orthopaedics and Plastic and Reconstructive Surgery in various roles of increasing responsibility. Mark holds a BBA in Marketing and Business administration from Western Michigan University. Dr. Justin Saliman practices orthopaedic surgery with a sports focus at Cedars-Sinai Hospital in Los Angeles. He founded and ran the incubator Revolutionary Surgical Device, LLC in late 2007 which went on to create SuturePro Technologies, LLC and Advanced Meniscus Technologies, LLC in 2009. These companies were merged in 2010 to form Ceterix Orthopaedics. Justin completed medical school at the University of Colorado School of Medicine in his hometown of Denver. He completed his residency in orthopaedic surgery at St. Lukes – Roosevelt Hospital center of Columbia University in New York City and a sports fellowship at Stanford University in Palo Alto. Kevin Sidow has been President and Chief Executive Officer for Moximed, Inc since 2004. Prior to this he was President and CEO for St. Francis Medical Technologies, Inc., a privately held company focused on developing innovative treatments for patients suffering from degenerative spinal disorders. The Company raised a total of $28 million in venture capital. In January 2007, St. Francis Medical Technologies, Inc. was sold for $725 million to Kyphon, Inc. Prior to joining SFMT, Kevin was the Worldwide President of DePuy Inc. As former Worldwide President of DePuy, he oversaw the global orthopaedic, spine, trauma, and sports medicine businesses and has over 20 years of orthopaedic medical device experience. His responsibilities included the combined worldwide reconstructive business (hips, knee, extremities, operating room products, ACE and casting), Spine, Mitek (sports medicine) and Biologics with annual revenue responsibility of over $3 billion. Dr. Justin Saliman practices orthopaedic surgery with a sports focus at Cedars-Sinai Hospital in Los Angeles. He founded and ran the incubator Revolutionary Surgical Device, LLC in late 2007 which went on to create SuturePro Technologies, LLC and Advanced Meniscus Technologies, LLC in 2009. These companies were merged in 2010 to form Ceterix Orthopaedics. Justin completed medical school at the University of Colorado School of Medicine in his hometown of Denver. He completed his residency in orthopaedic surgery at St. Lukes – Roosevelt Hospital center of Columbia University in New York City and a sports fellowship at Stanford University in Palo Alto.